Abstract
Background and purpose In most cancer sites a low socioeconomic status (SES) is consistently associated with poorer survival. For brain metastasis, this relation is not well understood. Therefore, we studied the effect of SES on survival in Dutch brain metastasis patients treated with stereotactic radiosurgery in a tertiary radiotherapy facility.
Materials and methods We retrospectively studied 404 consecutive patients treated with stereotactic radiosurgery for brain metastases in a tertiary referral centre between 2012 and 2017. Baseline prognostic factors for survival were collected. The SES score was based on education, income and employment. Cox proportional hazard models were made, corrected for the relevant variables identified from a directed acyclic graph (DAG). Adjustments were made in two ways in order to obtain comprehensive results: correcting for confounders (total effect), and correcting for confounders and mediating factors (direct effect).
Results Unadjusted, estimation of the linear effect of SES on survival resulted in a HR of 0.92 (95%CI 0.82 – 1.04). The total effect of SES was achieved by correcting for age, resulting in a HR of 0.95, with a 95% CI of 0.84 – 1.07. The direct effect gave a HR of 0.96 (95%CI 0.84 – 1.10).
Conclusion SES was not associated with survival in patients with brain metastases undergoing radiation therapy. When correcting for clinical variables, we found no significant relationship between SES and survival, with HRs suggesting limited clinical impact. The results suggest that patients’ survival outcomes after contemporary cancer treatment are unrelated to their employment status, education status and annual income.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University Medical Center Utrecht gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- AIC
- Akaike information criterion
- DAG
- directed acyclic graph
- DS-GPA
- disease-specific Graded Prognostic Assessment
- GBA
- Gemeentelijke Basisadministratie (Municipal Personal Records Database)
- GI
- gastro-intestinal
- GK
- Gamma Knife
- IPW
- inverse probability weighting
- KPS
- Karnofsky performance status
- NSCLC
- non-small-cell lung carcinoma
- RCC
- renal cell cancer
- RT
- radiotherapy
- SCP
- (Netherlands Institute for Social Research)
- SES
- socioeconomic status
- SRS
- stereotactic radiosurgery
- FSRT
- fractionated stereotactic radiotherapy